Home › Compare › OMHE vs JNJ

OMHE vs JNJ: Dividend Comparison 2026

OMHE yields 6666666.67% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OMHE wins by $8.25873857526507e+44M in total portfolio value
10 years
OMHE
OMHE
● Live price
6666666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.25873857526507e+44M
Annual income
$825,849,488,962,360,000,000,000,000,000,000,000,000,000,000,000,000.00
Full OMHE calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — OMHE vs JNJ

📍 OMHE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOMHEJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OMHE + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
OMHE pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OMHE
Annual income on $10K today (after 15% tax)
$566,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$701,972,065,618,006,100,000,000,000,000,000,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, OMHE beats the other by $701,972,065,618,006,100,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OMHE + JNJ for your $10,000?

OMHE: 50%JNJ: 50%
100% JNJ50/50100% OMHE
Portfolio after 10yr
$4.129369287632535e+44M
Annual income
$412,924,744,481,180,000,000,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
100.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

OMHE
No analyst data
Altman Z
0.5
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OMHE buys
0
JNJ buys
0
No recent congressional trades found for OMHE or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOMHEJNJ
Forward yield6666666.67% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$8.25873857526507e+44M$20.0K ✓
Annual income after 10y$825,849,488,962,360,000,000,000,000,000,000,000,000,000,000,000,000.00 ✓$827.78
Total dividends collected$8.258722632802889e+44M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: OMHE vs JNJ ($10,000, DRIP)

YearOMHE PortfolioOMHE Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$666,677,367$666,666,666.67$10,676$355.77+$666.67M → OMHE
2$41,538,243,978,220$41,537,530,633,437.17$11,407$389.39+$41538243.97M → OMHE
3$2,418,785,178,923,619,000$2,418,740,733,002,562,000.00$12,198$426.53+$2418785178923.61M → OMHE
4$131,632,535,180,835,430,000,000$131,629,947,080,693,970,000,000.00$13,056$467.62+$131632535180835424.00M → OMHE
5$6,694,929,569,421,761,000,000,000,000$6,694,788,722,609,116,000,000,000,000.00$13,987$513.12+$6.69492956942176e+21M → OMHE
6$318,233,313,948,923,370,000,000,000,000,000$318,226,150,374,284,100,000,000,000,000,000.00$14,998$563.56+$3.1823331394892335e+26M → OMHE
7$14,137,160,116,927,522,000,000,000,000,000,000,000$14,136,819,607,281,600,000,000,000,000,000,000,000.00$16,098$619.52+$1.4137160116927522e+31M → OMHE
8$586,942,647,681,175,100,000,000,000,000,000,000,000,000$586,927,520,919,850,000,000,000,000,000,000,000,000,000.00$17,295$681.69+$5.8694264768117504e+35M → OMHE
9$22,774,359,015,829,920,000,000,000,000,000,000,000,000,000,000$22,773,730,987,196,898,000,000,000,000,000,000,000,000,000,000.00$18,599$750.82+$2.277435901582992e+40M → OMHE
10$825,873,857,526,507,000,000,000,000,000,000,000,000,000,000,000,000$825,849,488,962,360,000,000,000,000,000,000,000,000,000,000,000,000.00$20,022$827.78+$8.25873857526507e+44M → OMHE

OMHE vs JNJ: Complete Analysis 2026

OMHE — Stock

Omni Health, Inc., through its subsidiary, Malecon Pharmacy, Inc., operates a pharmacy in Hialeah, Florida. It provides health, wellness, and pharmacy services; and manufactures, sells, and distributes anti-aging cream. The company is headquartered in Hialeah, Florida. Omni Health, Inc. is a subsidiary of LX Retail Group, Inc.

Full OMHE Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this OMHE vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OMHE vs SCHDOMHE vs JEPIOMHE vs OOMHE vs KOOMHE vs MAINOMHE vs ABBVOMHE vs MRKOMHE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.